Senti Biosciences Stock Alpha and Beta Analysis

SNTI Stock  USD 2.17  0.05  2.36%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Senti Biosciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Senti Biosciences over a specified time horizon. Remember, high Senti Biosciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Senti Biosciences' market risk premium analysis include:
Beta
0.36
Alpha
(0.26)
Risk
4.63
Sharpe Ratio
(0.05)
Expected Return
(0.25)
Please note that although Senti Biosciences alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Senti Biosciences did 0.26  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Senti Biosciences stock's relative risk over its benchmark. Senti Biosciences has a beta of 0.36  . As returns on the market increase, Senti Biosciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Senti Biosciences is expected to be smaller as well. As of now, Senti Biosciences' Book Value Per Share is increasing as compared to previous years. The Senti Biosciences' current Tangible Book Value Per Share is estimated to increase to 15.83, while Enterprise Value Over EBITDA is projected to decrease to (0.53).

Enterprise Value

29.47 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Senti Biosciences Backtesting, Senti Biosciences Valuation, Senti Biosciences Correlation, Senti Biosciences Hype Analysis, Senti Biosciences Volatility, Senti Biosciences History and analyze Senti Biosciences Performance.
For more detail on how to invest in Senti Stock please use our How to Invest in Senti Biosciences guide.

Senti Biosciences Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Senti Biosciences market risk premium is the additional return an investor will receive from holding Senti Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Senti Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Senti Biosciences' performance over market.
α-0.26   β0.36

Senti Biosciences expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Senti Biosciences' Buy-and-hold return. Our buy-and-hold chart shows how Senti Biosciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Senti Biosciences Market Price Analysis

Market price analysis indicators help investors to evaluate how Senti Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Senti Biosciences shares will generate the highest return on investment. By understating and applying Senti Biosciences stock market price indicators, traders can identify Senti Biosciences position entry and exit signals to maximize returns.

Senti Biosciences Return and Market Media

The median price of Senti Biosciences for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 is 2.27 with a coefficient of variation of 14.33. The daily time series for the period is distributed with a sample standard deviation of 0.35, arithmetic mean of 2.45, and mean deviation of 0.31. The Stock received some media coverage during the period.
 Price Growth (%)  
       Timeline  
1
Acquisition by Rajangam Kanya of 327750 shares of Senti Biosciences subject to Rule 16b-3
09/18/2024
2
Acquisition by Farokhzad Omid of 62500 shares of Senti Biosciences at 0.31 subject to Rule 16b-3
09/27/2024
3
Acquisition by Forbes Christopher of 17464 shares of Senti Biosciences at 2.77 subject to Rule 16b-3
10/04/2024
4
Senti Bio Announces Third Quarter 2024 Results and Recent Pipeline and Corporate Highlights
11/14/2024
5
Senti Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
11/20/2024

About Senti Biosciences Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Senti or other stocks. Alpha measures the amount that position in Senti Biosciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Payables Turnover0.582.864.28.2
Days Of Inventory On Hand315.65306.25275.62165.99

Senti Biosciences Upcoming Company Events

As portrayed in its financial statements, the presentation of Senti Biosciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Senti Biosciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Senti Biosciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Senti Biosciences. Please utilize our Beneish M Score to check the likelihood of Senti Biosciences' management manipulating its earnings.
27th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Senti Biosciences

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Senti Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Senti Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Senti Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Senti Biosciences Stock:
Senti Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Senti Biosciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Senti Biosciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...